Feb 23, 2016 21:05 pm UTC| Business
COLUMBUS, Ohio, Feb. 23, 2016 -- Bravo Brio Restaurant Group, Inc. (NASDAQ:BBRG) (the Company), owner and operator of the BRAVO! Cucina Italiana (BRAVO!) and BRIO Tuscan Grille (BRIO) restaurant concepts, today reported...
Retail Opportunity Investments Corp. Reports Strong 2015 Results
Feb 23, 2016 21:05 pm UTC| Business
12.9% Increase in FFO Per Share (19.0% Increase in 4Q) Establishes 2016 FFO Guidance Increases Cash Dividend by 5.9% SAN DIEGO, Feb. 23, 2016 -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today...
Revance to Participate in Upcoming Investor Conferences
Feb 23, 2016 21:05 pm UTC| Business
NEWARK, Calif., Feb. 23, 2016 -- Revance Therapeutics, Inc. (NASDAQ:RVNC), a specialty biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications, announced today that...
Adamas Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 23, 2016 21:05 pm UTC| Business
EMERYVILLE, Calif., Feb. 23, 2016 -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced financial results for the fourth quarter and full year ended December 31, 2015. Adamas reported a net loss attributable to...
Enphase Energy Reports Financial Results for the Fourth Quarter and Fiscal Year 2015
Feb 23, 2016 21:05 pm UTC| Business
PETALUMA, Calif., Feb. 23, 2016 -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company, announced today financial results for the fourth quarter and year ended December31, 2015. Enphase Energy...
Five9 Announces Revenue Growth of 27% and Positive Adjusted EBITDA for the Fourth Quarter of 2015
Feb 23, 2016 21:05 pm UTC| Business
Q4 LTM Enterprise Subscription Revenue Increased 38% Year-Over-Year Record Annual Revenue of $128.9 Million, Up 25% Year-Over-Year SAN RAMON, Calif., Feb. 23, 2016 -- Five9, Inc. (NASDAQ:FIVN), a leading provider...
BioBlast Pharma Reports Fourth Quarter and Full Year 2015 Financial Results
Feb 23, 2016 21:05 pm UTC| Business
NEW HAVEN, Conn., Feb. 23, 2016 -- BioBlast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced financial results for the fourth quarter and fiscal year ended...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects